Health System Costs for Stage-Specific Breast Cancer: A Population-Based Approach
Nicole Mittmann(Western University), Craig C. Earle(Canadian Partnership Against Cancer), Jeffrey S. Hoch(St. Michael's Hospital), Natasha B. Leighl(Princess Margaret Cancer Centre), Soo Jin Seung(Sunnybrook Research Institute), Ning Liu, Matthew C. Cheung(Simon Fraser University), J. Porter(Institute for Clinical Evaluative Sciences), William K. Evans(NHS Forth Valley), Maureen Trudeau(Trillium Health Centre), Katie N. Dainty(St. Michael's Hospital), Refik Saskin(Ontario Institute for Cancer Research), J. Rangrej(Institute for Clinical Evaluative Sciences), Carlo DeAngelis(Sunnybrook Health Science Centre)
Cited by 69
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
|The Lancet|2014|1.8k
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
|Journal of Clinical Oncology|2009|1.5k
Part 4: Advanced Life Support
|Circulation|2015|1.4k
Trends in the Aggressiveness of Cancer Care Near the End of Life
|Journal of Clinical Oncology|2004|995